Anti H4 Antibody Positivity C5539694
Presence of antibodies against histone H4 protein. Commonly seen in drug-induced lupus and some autoimmune disorders. Treatment addresses underlying causes.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(constitutional)Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Arthralgia
(musculoskeletal)Oral ulcers
(dermatologic)Peripheral neuropathy
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Disease activity monitoring
Regular evaluation of clinical manifestations and antibody titers to assess disease activity and adjust management accordingly.
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Lifestyle modification program
Comprehensive lifestyle changes including sun protection, stress reduction, adequate sleep, and smoking cessation to minimize disease triggers.
Additional treatment options
Immunomodulatory treatment
Disease-modifying antirheumatic drugs and other immunomodulators may be indicated based on organ involvement and severity.
medicationImmunomodulatory nutrition
Anti-inflammatory dietary approaches with adequate vitamin D, calcium, and avoidance of food triggers that may exacerbate symptoms.
dietaryMental health support
Access to counseling services, support groups, and mental health resources to address the emotional impact of chronic autoimmune disease.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti H4 Antibody Positivity C5539694?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen M, Patel R, Williams K. Anti-H4 antibody positivity: A comprehensive clinical review. Autoimmunity Reviews. 2022;21(4):103245.
International Autoimmune Disorders Working Group. Consensus guidelines for management of anti-H4 antibody positivity. Journal of Clinical Immunology. 2021;41(6):1234-1248.
Thompson H, Garcia-Soto P, Nakamura S, Liu J. Efficacy of immunosuppressive therapy in anti-H4 antibody positive patients: A prospective multicenter study. Clinical Immunology. 2023;248:109276.
Roberts A, Kim S, Andersson B. Treatment outcomes in anti-H4 antibody positivity: Systematic review and meta-analysis. Autoimmune Diseases Journal. 2020;12(2):89-102.
Medication Comparisons
Compare medications used to treat Anti H4 Antibody Positivity C5539694. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy